Market News Latest

Sheridan, United States – November 3, 2026 –

OsteoIQ’s Bone Turnover Marker Bundle gives direct-to-consumer access to both markers starting at $269, with retesting available every 3, 6, or 12 months and real-time tracking through the Bone Health Intelligence app.

OsteoIQ, the at-home bone health testing company, is expanding consumer education around CTX and P1NP blood testing this fall as more health-conscious adults move beyond general awareness of osteoporosis risk and start asking which specific tools can tell them what’s actually happening in their bones right now.

That’s a sharper question than it sounds, and the answer matters.

What These Two Markers Actually Measure A bone density scan shows structure accumulated over years. It doesn’t show what’s happening to that structure today. CTX, or C-terminal telopeptide of type I collagen, reflects the current rate at which bone tissue is being broken down. P1NP, or procollagen type I N-terminal propeptide, reflects the rate at which new bone is being formed. When both are measured together, they reveal whether the remodelling cycle is in balance, trending toward net loss, or shifting in a more favorable direction. That signal appears in blood, often months before any structural change would register on imaging.

That’s the core reason these markers are drawing attention from people who are already taking action on their bone health. Someone who’s adjusted their vitamin D intake, added a consistent weight-bearing exercise routine, or refined a supplement protocol wants to know whether those changes are actually reaching the biology. CTX and P1NP provide that feedback loop. A DXA scan gives you a picture of the past. These markers give you a read on the present.

It’s worth being precise about what they don’t do, though. A bone turnover marker result isn’t a diagnosis. Elevated CTX, for instance, can reflect several factors beyond straightforward bone loss, and a result without clinical context is genuinely incomplete. OsteoIQ’s Bone Health Intelligence app organizes results clearly and consistently directs users to involve their healthcare provider in any clinical interpretation. The tests are built for informed, ongoing monitoring, not as a standalone substitute for medical care.

OsteoIQ’s Bone Turnover Marker Bundle OsteoIQ’s Bone Turnover Marker Bundle measures both CTX and P1NP and starts at $269. No physician referral is required to order, and testing is available worldwide through a direct-to-consumer model. Retesting is available on 3, 6, or 12-month intervals, which makes these markers genuinely usable as leading indicators between less frequent DXA appointments rather than one-off data points. Every purchase includes access to the Bone Health Intelligence app, which tracks results across multiple tests and delivers personalized, data-driven insights.

Consider what that looks like in a common situation. Someone in their mid-fifties receives a borderline DXA result and makes meaningful changes to their routine: a new supplement protocol, consistent resistance training, and dietary adjustments. In a typical scenario like that, a structural measure might not reflect those efforts for well over a year. CTX and P1NP could potentially show whether the remodelling balance is shifting in a healthier direction well before that window closes. The real cost of skipping bone marker testing isn’t $269. It’s the 12 to 24 months spent putting in genuine effort with no feedback on whether any of it is working.

Adding a Genomic Layer OsteoIQ’s Optimal Genomics test, starting at $379, adds a dimension that a density scan can’t reach at all. It analyzes genetic variants tied to vitamin D metabolism, calcium absorption, and other factors that shape individual bone health susceptibility. Two people can carry similar DXA scores and have meaningfully different underlying tendencies driving their bone biology.

Knowing which genetic factors are in play helps shift the focus from reactive measurement toward proactive, personalized management. That’s what OsteoIQ means by Bone Health Intelligence: not just a number, but a picture with enough detail to act on.

About OsteoIQ

OsteoIQ provides at-home bone turnover marker testing and genomic bone health analysis through a direct-to-consumer model available worldwide. Its Bone Turnover Marker Bundle measures CTX and P1NP starting at $269, with retesting intervals of 3, 6, or 12 months for ongoing monitoring of bone remodelling activity. Its Optimal Genomics test starts at $379 and analyzes genetic variants relevant to individual bone health risk. Every test purchase includes access to the Bone Health Intelligence app, which organizes results over time and delivers personalized, data-driven insights to support proactive bone health management. Learn more at osteoiq.com.

Media Contact
Company Name: OsteoIQ
Contact Person: Media Relations
Email: Send Email
Phone: +1 855 856 9986
City: Sheridan, WY
Country: United States
Website: https://osteoiq.com